Pfizer Announcement Regarding Allergan plc
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/22/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- One killed, three injured when man attacks Swedish school with sword
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
Allergen (AGN) Should Buy Pfizer (PFE), Not the Other Way Around - Analyst
November 2, 2015 7:10 AM ESTRecent news points to Pfizer (NYSE: PFE) in preliminary talks to acquire Allergen (NYSE: AGN). However, according to one analyst, the deal should be the other way around.
Nomura Securities analyst Shibani Malhotra said Allergen... More
Allergen (AGN)/Pfizer (PFE) Deal Creates Mid-Teens Synergies in Year 2 - RBC Capital
October 29, 2015 10:40 AM EDTThe potential Allergan (NYSE: AGN)/Pfizer (NYSE: PFE) deal would bring attractive strategic and financial aspects and focus will shift to the likelihood of actually getting done if the price is right and management structure can be agreed... More
